Stem cells injected into brain to fight Parkinson's: first human test

NCT ID NCT07572071

Recruiting now Disease control Sponsor: Royan Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests whether transplanting 10 million special nerve cells made from stem cells into the brain is safe for people with moderate Parkinson's disease. Ten participants will receive the cells in a single surgery. The main goal is to check for side effects and see if the procedure is feasible, not yet to prove it works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (PD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE (PD)

Contacts and locations

Locations

Iran University of Medical Sciences
RECRUITING

Tehran, Iran
Royan Institute
RECRUITING

Tehran, Iran
Shiraz University of Medical Sciences
RECRUITING

Shiraz, Iran

More trials for these conditions

Other studies related to the condition(s) this trial covers.